By the end of 2010 the company in gene sequencing industry were pushing aggressive R & D program for the development of technologies and products in the race sequence the entire human genome at a cost of $ 1,000. It still was not clear when the "$ 1000 genome" comes, and, despite all the buzz surrounding the industry, it was not clear to investors that the industry will be winners. This case focuses on the emergence of a third-generation sequencing and the four segments in the industry: equipment, supplies, services and interpretation. The case presents the story of industry, development of sequencing technologies and business models of players in each segment.
To enhance their effectiveness, color cases should be printed in color. "Hide
by Richard G. Hamermesh, Mara G. Aspinall, Philip Andrews Source: HBS 22 pages. Publication Date: October 17, 2011. Prod. #: 812004-PDF-ENG
Related Case Solutions & Analyses:
HSBC–The Bital Acquisition
Intel Corp.: The Hood River Project (A)
Triage at Rouge Valley Health System
Applying the principles of branding to build personal brands
Indian Steel Ltd: Tri-Party Negotiation – The Buyer (A)
Target of Opportunity: South Africa’s Western Cape Seeks a Role in the African Oil Boom
Konys, Inc.
Leading Across Cultures at Michelin (B)
The Dojima Rice Market and the Origins of Futures Trading
Servientrega: Founders in Competition (Spanish) Spanish
